Ignite Creation Date:
2024-05-06 @ 7:29 PM
Last Modification Date:
2024-10-26 @ 3:07 PM
Study NCT ID:
NCT06022757
Status:
RECRUITING
Last Update Posted:
2024-02-23
First Post:
2023-08-17
Brief Title:
Study of XNW5004 Tablet in Combination With KEYTRUDA Pembrolizumab in Subjects With Advanced Solid Tumors Who Failed Standard Treatments KEYNOTE F19
Sponsor:
Evopoint Biosciences Inc
Organization:
Evopoint Biosciences Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-09-20
Start Date Type:
ACTUAL
Primary Completion Date:
2028-08
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-08
Completion Date Type:
ESTIMATED
First Submit Date:
2023-08-17
First Submit QC Date:
August 31 2023
Study First Post Date:
2023-09-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-21
Last Update Post Date:
2024-02-23
Last Update Post Date Type:
ACTUAL